drugset / Trial / NCT00643604
Rapid Switch From Flolan to Remodulin in the Outpatient Clinic
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this 8-week study is to compare the effects of switching from therapy with epoprostenol or Flolan to IV Remodulin. This study will also assess the effect that changing to Remodulin will have on patient satisfaction with their treatment and impact on quality of life.
Timeline
- Start
- 2008-03
- Primary completion
- 2010-01
- Completion
- 2012-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Treprostinil | Other / unclassified | — | Intravenous |